Priceline shares cruised to their highest altitude ever Wednesday after the company beat second-quarter estimates, while CEO Darren Huston shed light on the online travel agency’s social media partnerships. “I was quite skeptical, but I have to give Facebook (FB) a ton of credit. We’re finally getting some good business out of Facebook,” he said during a conference call, admitting that Priceline has “always struggled” with accessing
Specialty drugmaker and IBD 50 stock Jazz Pharmaceuticals reported Q2 earnings in line with estimates and affirmed its guidance late Wednesday, but its revenue came up a bit short of expectations. Jazz (JAZZ) said that its earnings rose 19% over the year-earlier quarter to $2.41 a share, while revenue increased 15% to $333.7 million. Analysts expected $335.9 million in revenue. The EPS number matched their estimate, according to Thomson Reuters.
Wearable fitness device maker Fitbit (FIT) late Wednesday crushed Wall Street’s second-quarter sales and earnings targets and guided above consensus for Q3 and the full year. In its first quarterly report as a publicly traded company, Fitbit said earnings jumped 133% to 21 cents a share excluding items, well above views of 8 cents. Sales soared 253% to $400 million, topping estimates of $319 million. But Fitbit’s stock sank 14.6% to 44.09 in